UPDATE 1-Thermo Fisher buys Henogen for nearly $880 mln in gene therapy expansion [Reuters]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Reuters
By Reuters Staff 1 Min Read (Reuters) - Medical device maker Thermo Fisher Scientific Inc said on Friday it has bought Henogen SA, a Belgium-based viral vector manufacturing business, for about 725 million euros ($879.72 million) in cash. The acquisition, from contract manufacturing services provider Novasep, will help expand Thermo Fisher’s capabilities for cell and gene vaccines and therapies, Thermo Fisher said in a statement. In 2019, Thermo Fisher bought Brammer Bio, a contract development and manufacturing organization that specialized in making viral vectors, used in gene therapies to deliver genetic materials into defective cells. Henogen has about 400 employees and is estimated to have generated revenue of 80 million euros ($97.04 million) in 2020, Thermo Fisher said. The business will be part of Thermo Fisher’s pharma services business, it said.
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Global Artificial Intelligence in Forensic Science Market Size is Expected To Hold a Significant Share By 2033 | CAGR Of 13.8% [Yahoo! Finance]Yahoo! Finance
- Curida, Small Molecules and Biologics CDMO, Secures Private Equity Investment from Signet Healthcare Partners [Yahoo! Finance]Yahoo! Finance
- What's in Store for Thermo Fisher (TMO) in Q1 Earnings? [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific: Too Hot To Handle [Seeking Alpha]Seeking Alpha
- Cell Culture Market is Expected to Reach $57.9 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 1/31/24 - Beat
TMO
Sec Filings
- 4/9/24 - Form ARS
- 4/9/24 - Form DEFA14A
- 4/9/24 - Form DEF
- TMO's page on the SEC website